Bellino S. COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients. Ann Med 2022;54:2856-60. [PMID: 36259490 DOI: 10.1080/07853890.2022.2133162][Reference Citation Analysis]
4
Weng TC, Weng TS, Lai CC, Chao CM, Wang JH. Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther 2022;20:1615-22. [PMID: 36317748 DOI: 10.1080/14787210.2022.2142117][Reference Citation Analysis]
5
Poznański P, Augustyniak-Bartosik H, Magiera-Żak A, Skalec K, Jakuszko K, Mazanowska O, Janczak D, Krajewska M, Kamińska D. Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients. Viruses 2022;14:2224. [PMID: 36298779 DOI: 10.3390/v14102224][Reference Citation Analysis]
